Titan Medical Inc (TMDIF)

[JMAC13]

BTIG Update: Titan was not rated by BTIG. Sean Lavin, head analyst of Med Device for BTIG did however rate TRXC as a Buy and with a $6 PT. He was concerned about Surgibot not getting approval Q1 stating Q2 was more likely. TRXC will be showcasing both robots at SAGES.

They also rated J&J as a buy w/ a $115 PT and only had ONE measly line from the company on there robot. "we are positive on our efforts with robotic surgery"

Titan was one of a handful of the 60 companies not rated. I wonder what precursors where needed to get a write-up?

Anyway, I hope they got some interest out of that conference and at least could of held their own against TRXC at the conference.

L&S